Skip to main content

Table 3 Persistence to index statin therapy by patients from the high TG (200–499 mg/dL) and matched comparator cohorts

From: Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis

Persistence Parameter, Mean (SD)

High-TG Subcohorta

(n = 10,990)

Comparator Cohortb

(n = 10,990)

P Value

6-month PDC

0.76 (0.26)

0.76 (0.26)

0.707

Overall PDC

0.67 (0.30)

0.68 (0.29)

0.012

Months to discontinuationc

10.1 (12.7)

9.9 (12.7)

0.284

  1. aTG ≥200–499 mg/dL
  2. bTG < 150 mg/dL and HDL-C > 40 mg/dL; propensity score matched to high-TG cohort
  3. cFor patients who discontinued
  4. Rao-Scott test was used for binary measures; robust standard errors were used for continuous measures
  5. P values calculated for comparison between the high-TG cohort and its propensity-matched comparator cohort
  6. HDL-C high-density lipoprotein cholesterol, PDC proportion of days covered, SD standard deviation, TG triglycerides